PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
March 19, 2024GastroenterologyOpen Access

Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction

View Full Paper
Ask AI
Bookmark
Share

Authors

LKLaurens A. van KleefSFSven FrancqueJOJhon Edison Prieto Ortíz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kleef et al. (2024) studied this question.

synapsesocial.com/papers/68e734edb6db6435876ae2c3https://doi.org/10.1053/j.gastro.2024.03.017
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD2024 · 24 citations
  2. 2Non-invasive prediction nomogram for predicting significant fibrosis in patients with metabolic-associated fatty liver disease: a cross-sectional study2024 · 2 citations
  3. 3Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver disease2024 · 6 citations
  4. 4Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care2024 · 3 citations
  5. 5The prognostic role of Fibrosis-4 score in heart failure with reduced ejection fraction2025 · 7 citations